# Citi

Type: Company (C)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/citi
Canonical HTML page: https://gethealthbrief.com/entity/citi

## Recent coverage (2 stories)

### Citi Trims GE HealthCare Price Target Amid Shifting MedTech Macro Dynamics
2026-03-23 14:38:44 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Citi has lowered its price target for GE HealthCare Technologies (GEHC), signaling a cautious outlook on the medical imaging giant's near-term growth trajectory. The adjustment reflects broader sector concerns regarding capital equipment spending and regional market volatility in the healthcare technology space.
Full story: https://gethealthbrief.com/story/citi-reduces-gehc-price-target-analysis

### Hims & Hers Surges 41% on Landmark GLP-1 Distribution Deal with Novo Nordisk
2026-03-10 00:20:04 · Sentiment: Positive · Impact: 7/10 · Sources: 3

Hims & Hers Health has secured a strategic partnership with Novo Nordisk to distribute branded GLP-1 medications, effectively ending a high-stakes patent dispute. The deal marks a pivotal shift for the telehealth provider from compounded alternatives to FDA-approved Ozempic, triggering a massive 41% rally in its share price.
Full story: https://gethealthbrief.com/story/hims-and-hers-novo-nordisk-glp1-partnership

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.